Cryofocus Medtech Achieves Fable Intervening time Outcomes with 162% Income Surge Driven by Respiratory Intervention Products

HONG KONG, Aug 11, 2025 – (ACN Newswire) – Cryofocus Medtech (Shanghai) Co., Ltd. (“Cryofocus” or the “Company,” Stock Code: 6922.HK), a global innovator in minimally invasive interventional cryotherapy, final friday announced its unaudited intervening time outcomes for the six months ended June 30, 2025. The Company demonstrated strong state momentum and crucial operational optimization throughout the reporting period…
Be taught Extra